Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Appl Environ Microbiol. 2003 Jan;69(1):186-90.

    Degradation of anthracene by Mycobacterium sp. strain LB501T proceeds via a novel pathway, through o-phthalic acid.

    Source

    Department of Environmental and Toxicological Chemistry (IBED/MTC), University of Amsterdam, 1018WV Amsterdam, The Netherlands.

    Erratum in

    • Appl Environ Microbiol. 2003 May;69(5):3026.

    Abstract

    Mycobacterium sp. strain LB501T utilizes anthracene as a sole carbon and energy source. We analyzed cultures of the wild-type strain and of UV-generated mutants impaired in anthracene utilization for metabolites to determine the anthracene degradation pathway. Identification of metabolites by comparison with authentic standards and transient accumulation of o-phthalic acid by the wild-type strain during growth on anthracene suggest a pathway through o-phthalic acid and protocatechuic acid. As the only productive degradation pathway known so far for anthracene proceeds through 2,3-dihydroxynaphthalene and the naphthalene degradation pathway to form salicylate, this indicates the existence of a novel anthracene catabolic pathway in Mycobacterium sp. LB501T.

    PMID:
    12513994
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC152392
    Free PMC Article

    Images from this publication.See all images (2)Free text

    FIG. 1.
    FIG. 2.

      Supplemental Content

      Icon for HighWire Icon for PubMed Central

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk